FreeIn Brief Milan Mrksich named associate director for research technology and infrastructure at Lurie Cancer Center October 02, 2014Vol.40 No.41
Drugs & TargetsFree National Comprehensive Cancer Network approves VeriStrat predictive proteomics test October 02, 2014Vol.40 No.41
FreeTCCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says October 01, 2014Vol.37 No.09
FreeTCCL Archive Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II October 01, 2014Vol.37 No.09
FreeTCCL Archive Phase III Xilonix Study Halted Following Unscheduled Analysis October 01, 2014Vol.37 No.09
FreeTCCL Archive Phase III Trial: Panobinostat Increases PFS by Four Months October 01, 2014Vol.37 No.09
